Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2011

01-06-2011 | Original Article

Transition of young adults with phenylketonuria from pediatric to adult care

Authors: Ulrike Mütze, Annika Roth, Johannes F. W. Weigel, Skadi Beblo, Christoph G. Baerwald, Peter Bührdel, Wieland Kiess

Published in: Journal of Inherited Metabolic Disease | Issue 3/2011

Login to get access

Abstract

Background

Transition from pediatric to adult health care is a particularly vulnerable period for patients with inborn metabolic diseases. Aim of the present study was to evaluate the current transition situation of patients with phenylketonuria (PKU) in Leipzig, Germany, by analysis of the medical care, metabolic control, patients’ satisfaction, socio-economic and psychosocial status, in order to identify areas of weakness and potential improvement.

Methods

Patients who had been transferred from pediatric to adult medical care between 2005 and 2008 were identified. An interview was performed using a questionnaire. Pediatric case notes and the present physician’s case notes were analyzed retrospectively. Socio-demographic data were compared to data derived from the annual statistics of the city of Leipzig, Germany in 2008.

Results

seventy two transferred patients were identified and included in the study, 48 patients responded to the questionnaire, the data of 24 non-responders were analysed retrospectively. About 90% of the responding patients with PKU were satisfied with the current transition situation. However, they agreed to several suggestions of improvement. Most specifically an interdisciplinary appointment before the definite transfer to the adult clinics was asked for. At the time of transition, most of the patients were in good metabolic control according to current treatment guidelines (median dried blood phenylalanine concentration 853 μmol/l before versus 690 μmol/l after transition). Of the interviewed patients 92% were still on a low phenylalanine diet in combination with the intake of a phenylalanine free amino acid mixture. Of the interviewees 77% carried a secondary school certificate or a secondary modern school qualification, but only 19% had achieved senior high school diploma (controls 38.2%). Marital status was comparable with the population of Leipzig. However, fewer patients with PKU had children (15% versus 37%).

Conclusion

Transition of patients with PKU from pediatric to adult care seems to be successful in Leipzig. Patients were mostly satisfied with the transition situation. Still, some suggestions for improvements appeared to be desirable. During transition medical care and metabolic control were stable. However, with regard to psychosocial and socioeconomic data differences to the control population were detected.
Literature
go back to reference Acosta PB, Yannicelli S, Marriage B et al. (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287–291PubMedCrossRef Acosta PB, Yannicelli S, Marriage B et al. (1998) Nutrient intake and growth of infants with phenylketonuria undergoing therapy. J Pediatr Gastroenterol Nutr 27:287–291PubMedCrossRef
go back to reference Bik-Multanowski M, Didycz B, Mozrzymas R et al. (2008) Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis 29 Bik-Multanowski M, Didycz B, Mozrzymas R et al. (2008) Quality of life in noncompliant adults with phenylketonuria after resumption of the diet. J Inherit Metab Dis 29
go back to reference Blau N, Bélanger-Quintana A, Demirkol M et al. (2010) Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab 99:109–115PubMedCrossRef Blau N, Bélanger-Quintana A, Demirkol M et al. (2010) Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab 99:109–115PubMedCrossRef
go back to reference Blum R (2002) Improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics 110:1301–1303PubMed Blum R (2002) Improving transition for adolescents with special health care needs from pediatric to adult-centered health care. Pediatrics 110:1301–1303PubMed
go back to reference Blum RW, Garell D, Hodgman CH et al. (1993) Transition from child-centered to adult health-care systems for adolescents with chronic conditions: a position paper for the Society of Adolescent Medicine. J Adolesc Health 14:570–576PubMedCrossRef Blum RW, Garell D, Hodgman CH et al. (1993) Transition from child-centered to adult health-care systems for adolescents with chronic conditions: a position paper for the Society of Adolescent Medicine. J Adolesc Health 14:570–576PubMedCrossRef
go back to reference Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30:29–34PubMedCrossRef Bosch AM, Tybout W, van Spronsen FJ, de Valk HW, Wijburg FA, Grootenhuis MA (2007) The course of life and quality of life of early and continuously treated Dutch patients with phenylketonuria. J Inherit Metab Dis 30:29–34PubMedCrossRef
go back to reference Bremer HJ, Bührdel P. Burgard, P, et al. (1997) Therapie von Patienten mit Phenylketonurie, Empfehlungen der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS) (German) MschrKinderheilk 145:961-962 Bremer HJ, Bührdel P. Burgard, P, et al. (1997) Therapie von Patienten mit Phenylketonurie, Empfehlungen der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS) (German) MschrKinderheilk 145:961-962
go back to reference Burgard P, Armbruster M, Schmitdt E, Rupp A (1994) Psychopathology of patients treated early for phenylketonuria: results of the German collabrorative study of phenylkotonuria. Acta Paediatr Suppl 407:108–110PubMedCrossRef Burgard P, Armbruster M, Schmitdt E, Rupp A (1994) Psychopathology of patients treated early for phenylketonuria: results of the German collabrorative study of phenylkotonuria. Acta Paediatr Suppl 407:108–110PubMedCrossRef
go back to reference Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155(Suppl 1):S33–S38PubMedCrossRef Burgard P, Schmidt E, Rupp A, Schneider W, Bremer HJ (1996) Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. Eur J Pediatr 155(Suppl 1):S33–S38PubMedCrossRef
go back to reference Busse FP, Hiermann P, Galler A et al. (2007) Evaluation of patients´ opinion and metabolic control after transfer of young adults with type 1 diabetes from a pediatric diabetes clinic to adult care. Horm Res 67:132–138PubMedCrossRef Busse FP, Hiermann P, Galler A et al. (2007) Evaluation of patients´ opinion and metabolic control after transfer of young adults with type 1 diabetes from a pediatric diabetes clinic to adult care. Horm Res 67:132–138PubMedCrossRef
go back to reference Callahan ST, Winitzer RF, Keenan P (2001) Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr 13:310–316PubMedCrossRef Callahan ST, Winitzer RF, Keenan P (2001) Transition from pediatric to adult-oriented health care: a challenge for patients with chronic disease. Curr Opin Pediatr 13:310–316PubMedCrossRef
go back to reference Ceglarek U, Müller P, Stach B, Bührdel P, Thiery J, Kiess W (2002) Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med 40:693–697PubMedCrossRef Ceglarek U, Müller P, Stach B, Bührdel P, Thiery J, Kiess W (2002) Validation of the phenylalanine/tyrosine ratio determined by tandem mass spectrometry: sensitive newborn screening for phenylketonuria. Clin Chem Lab Med 40:693–697PubMedCrossRef
go back to reference Channon S, Goodman G, Zlotowitz S, Mockler C, Lee PJ (2007) Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch Dis Child 92:213–218PubMedCrossRef Channon S, Goodman G, Zlotowitz S, Mockler C, Lee PJ (2007) Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch Dis Child 92:213–218PubMedCrossRef
go back to reference Dobbelaere D, Michaud L, Debrabander A et al. (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylkatonuria. J Inherit Metab Dis 26:1–11PubMedCrossRef Dobbelaere D, Michaud L, Debrabander A et al. (2003) Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylkatonuria. J Inherit Metab Dis 26:1–11PubMedCrossRef
go back to reference Feillet F, MacDonald A, Hartung D, Burton B (2010) Outcomes beyond phenylalanine: An international perspective. Mol Genet Metab 99:S79–S85PubMedCrossRef Feillet F, MacDonald A, Hartung D, Burton B (2010) Outcomes beyond phenylalanine: An international perspective. Mol Genet Metab 99:S79–S85PubMedCrossRef
go back to reference Bundesministerium für Bildung und Forschung (2006) Die wirtschaftliche und soziale Lage der Studierenden in der Bundesrepublik Deutschland 2006 S3 Bundesministerium für Bildung und Forschung (2006) Die wirtschaftliche und soziale Lage der Studierenden in der Bundesrepublik Deutschland 2006 S3
go back to reference Gassió R, Fusté E, López-Sala A, Artuch R, Vilaseca MA, Campistol J (2005) School performance in early and continuously treated phenylketonuria. Pediatr Neurol 33:267–271PubMedCrossRef Gassió R, Fusté E, López-Sala A, Artuch R, Vilaseca MA, Campistol J (2005) School performance in early and continuously treated phenylketonuria. Pediatr Neurol 33:267–271PubMedCrossRef
go back to reference Griffiths PV, Demellweek C, Fay N, Robinson PH, Davidson DC (2000) Wechsler subscale IQ and subtest profile in early treated phenylketonuria. Arch Dis Child 82:209–215PubMedCrossRef Griffiths PV, Demellweek C, Fay N, Robinson PH, Davidson DC (2000) Wechsler subscale IQ and subtest profile in early treated phenylketonuria. Arch Dis Child 82:209–215PubMedCrossRef
go back to reference Hardelid P, Cortina-Borja M, Munro A et al. (2008) The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England. Ann Hum Genet 72:65–71PubMed Hardelid P, Cortina-Borja M, Munro A et al. (2008) The birth prevalence of PKU in populations of European, South Asian and sub-Saharan African ancestry living in South East England. Ann Hum Genet 72:65–71PubMed
go back to reference Henrich G, Herschbach P (2000) Questions on life satisfaction (FLZM). EJPA 16:150–159 Henrich G, Herschbach P (2000) Questions on life satisfaction (FLZM). EJPA 16:150–159
go back to reference Hoeks MPA, den Heijer M, Janssen MCH (2009) Adult issues in phenylketonuria. Neth J Med 67:2–7PubMed Hoeks MPA, den Heijer M, Janssen MCH (2009) Adult issues in phenylketonuria. Neth J Med 67:2–7PubMed
go back to reference Huemer M, Huemer C, Mösliner D, Huter D, Stöckler-Ipsiroglu S (2007) Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis 30:694–699PubMedCrossRef Huemer M, Huemer C, Mösliner D, Huter D, Stöckler-Ipsiroglu S (2007) Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature. J Inherit Metab Dis 30:694–699PubMedCrossRef
go back to reference Jordan A, McDonagh J (2006) Transition: getting it right for young people. Clin Med 6:497–500PubMed Jordan A, McDonagh J (2006) Transition: getting it right for young people. Clin Med 6:497–500PubMed
go back to reference Landolt MA, Nuoffer JM, Steinmann B, Superti-Furga A (2002) Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 140:516–521PubMedCrossRef Landolt MA, Nuoffer JM, Steinmann B, Superti-Furga A (2002) Quality of life and psychologic adjustment in children and adolescents with early treated phenylketonuria can be normal. J Pediatr 140:516–521PubMedCrossRef
go back to reference MacDonald A, Asplin D (2006) Phenylketonuria: practical dietary management. J Fam Health Care 16:83–85PubMed MacDonald A, Asplin D (2006) Phenylketonuria: practical dietary management. J Fam Health Care 16:83–85PubMed
go back to reference MacDonald A, Davies P, Daly A et al. (2008) Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria? J Hum Nutr Diet 21:351–358PubMedCrossRef MacDonald A, Davies P, Daly A et al. (2008) Does maternal knowledge and parent education affect blood phenylalanine control in phenylketonuria? J Hum Nutr Diet 21:351–358PubMedCrossRef
go back to reference MacLeod EL, Gleason ST, van Calcar SC, Ney DM (2009) Reassessment of phenylalanine tolerance in adults with phenylaketonuria is needed as body mass changes. Mol Genet Metab 98:331–337PubMedCrossRef MacLeod EL, Gleason ST, van Calcar SC, Ney DM (2009) Reassessment of phenylalanine tolerance in adults with phenylaketonuria is needed as body mass changes. Mol Genet Metab 98:331–337PubMedCrossRef
go back to reference McGill M (2002) How do we organize smooth, effective transition from paediatric to adult diabetes care? Horm Res 57:66–68PubMedCrossRef McGill M (2002) How do we organize smooth, effective transition from paediatric to adult diabetes care? Horm Res 57:66–68PubMedCrossRef
go back to reference Michaud PA, Suris JC, Viner R (2004) The adolescent with a chronic condition. Part II: healthcare provision. Arch Dis Child 89:943–949PubMedCrossRef Michaud PA, Suris JC, Viner R (2004) The adolescent with a chronic condition. Part II: healthcare provision. Arch Dis Child 89:943–949PubMedCrossRef
go back to reference Musson DG, Kramer WG, Foehr ED et al. (2010) Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults. Clin Ther 32:338–342PubMedCrossRef Musson DG, Kramer WG, Foehr ED et al. (2010) Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults. Clin Ther 32:338–342PubMedCrossRef
go back to reference National Institut of Health Consensus Development Conference Statement (2005) Phenylketonuria: screening and management. J Inher Metab Dis 28(suppl1):18 National Institut of Health Consensus Development Conference Statement (2005) Phenylketonuria: screening and management. J Inher Metab Dis 28(suppl1):18
go back to reference Schidlow DV, Fiel SB (1990) Life beyond pediatrics: transition of chronically ill adolescents from pediatric to adult health care systems. Med Clin North Am 74:1113–1120PubMed Schidlow DV, Fiel SB (1990) Life beyond pediatrics: transition of chronically ill adolescents from pediatric to adult health care systems. Med Clin North Am 74:1113–1120PubMed
go back to reference Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16:681–688PubMedCrossRef Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville L (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level. J Clin Exp Neuropsychol 16:681–688PubMedCrossRef
go back to reference Schmidt H, Burgard P, Pietz J, Rupp A (1996) Intelligence and professional career in young adults treated early for phenylketonuria. Eur J Pediatr 155:97–100CrossRef Schmidt H, Burgard P, Pietz J, Rupp A (1996) Intelligence and professional career in young adults treated early for phenylketonuria. Eur J Pediatr 155:97–100CrossRef
go back to reference Schwarz M, Wendel U (2005) Inborn errors of metabolism (IEM) in adults: a new challenge to internal medicine. Med Klin 100:547–552CrossRef Schwarz M, Wendel U (2005) Inborn errors of metabolism (IEM) in adults: a new challenge to internal medicine. Med Klin 100:547–552CrossRef
go back to reference Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1998) The hyperphenylalaninemias. In: Scriver RC, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1015–1075 Scriver CR, Kaufman S, Eisensmith RC, Woo SLC (1998) The hyperphenylalaninemias. In: Scriver RC, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw-Hill, New York, pp 1015–1075
go back to reference Simon E, Schwarz M, Roos J et al. (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 6:25PubMedCrossRef Simon E, Schwarz M, Roos J et al. (2008) Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU). Health Qual Life Outcomes 6:25PubMedCrossRef
go back to reference Stadt Leipzig, Amt für Statistik und Wahlen (2008) Statistisches Jahrbuch 2008: 24, 27, 77, 82, 145 Stadt Leipzig, Amt für Statistik und Wahlen (2008) Statistisches Jahrbuch 2008: 24, 27, 77, 82, 145
go back to reference Stemerdink BA, Kalverboer AF, van der Meere JJ et al. (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23:548–562PubMedCrossRef Stemerdink BA, Kalverboer AF, van der Meere JJ et al. (2000) Behaviour and school achievement in patients with early and continuously treated phenylketonuria. J Inherit Metab Dis 23:548–562PubMedCrossRef
go back to reference Unger S, Weigel JF, Stepan H, Baerwald CG (2009) A case of maternal PKU syndrome despite intensive patient counseling. Wien Med Wochenschr 159:507–510PubMedCrossRef Unger S, Weigel JF, Stepan H, Baerwald CG (2009) A case of maternal PKU syndrome despite intensive patient counseling. Wien Med Wochenschr 159:507–510PubMedCrossRef
go back to reference Van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the needs for a new guideline. J Inherit Metab Dis 31:673–679PubMedCrossRef Van Spronsen FJ, Burgard P (2008) The truth of treating patients with phenylketonuria after childhood: the needs for a new guideline. J Inherit Metab Dis 31:673–679PubMedCrossRef
go back to reference Viner R (1999) Transition from paediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 81:271–275PubMedCrossRef Viner R (1999) Transition from paediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 81:271–275PubMedCrossRef
go back to reference Walter JH, White FJ, Hall SK et al. (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef Walter JH, White FJ, Hall SK et al. (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef
go back to reference Zeman J, Pijackova A, Behulova J, Urge O, Saligova HJ (1996) Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak collaborative study. Eur J Pediatr 155:56–58CrossRef Zeman J, Pijackova A, Behulova J, Urge O, Saligova HJ (1996) Intellectual and school performance in adolescents with phenylketonuria according to their dietary compliance. The Czech-Slovak collaborative study. Eur J Pediatr 155:56–58CrossRef
Metadata
Title
Transition of young adults with phenylketonuria from pediatric to adult care
Authors
Ulrike Mütze
Annika Roth
Johannes F. W. Weigel
Skadi Beblo
Christoph G. Baerwald
Peter Bührdel
Wieland Kiess
Publication date
01-06-2011
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2011
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9284-x

Other articles of this Issue 3/2011

Journal of Inherited Metabolic Disease 3/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.